Cladribine (CLAD) is a deoxyadenosine analogue prodrug which is given in multiple sclerosis (MS) as two short oral treatment courses 12 months apart. Reconstitution of adaptive immune function following selective immune cell depletion is the presumed mode of action. In this exploratory study. we investigated the impact of CLAD tablets on immune cell surface molecules for adhesion (CAM... https://powerlands.shop/product-category/powerland/